Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

    Use mouse models to test existing and investigational drugs for Alzheimer's; focus on drug repositioning and combo therapy development.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

    Funding for Alzheimer's drug development from pre-clinical to Phase I clinical trials to prevent, slow, or treat AD symptoms, excluding basic research and non-pharmacological interventions.

    HHS-NIH11Due Jan 6, 2027$1,500,000

    Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

    NIH supports genome editing and other biologic therapies for Alzheimer's disease-related dementias, from lead optimization and drug development through safety studies and early clinical evaluation.

    HHS-NIH11Due Feb 9, 2027$12,500,000

    Alzheimers Drug-Development Program (U01 Clinical Trial Optional)

    This grant supports academic and biotech researchers in developing new drugs to prevent, slow, or treat Alzheimer’s disease through preclinical and early-stage clinical research.

    HHS-NIH11Forecasted Jun 18, 2027Forecasted

    Drug Development RFP

    Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.

    Alzheimers Drug DiscoveryDue Dec 7, 2026· 18d$5,000,000

    Prevention RFP - Alzheimer's Drug Discovery Foundation

    Prevention RFP - Alzheimer's Drug Discovery Foundation supports researchers and clinicians conducting human studies of targeted interventions, combination therapies, and drug choices to reduce dementia risk.

    Alzheimers Drug DiscoveryForecasted Dec 7, 2026· 18d$5,000,000Forecasted